Literature DB >> 32498099

Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases.

Salvatore Paiella1, Luca Landoni1, Roberta Rota1, Matteo Valenti1, Giovanni Elio1, Stefano Francesco Crinò2, Erminia Manfrin3, Alice Parisi3, Sara Cingarlini4, Mirko D'Onofrio5, Aldo Scarpa3,6, Rita Teresa Lawlor6, Laura Bernardoni2, Paola Capelli3, Chiara Nessi1, Marco Miotto1, Armando Gabbrielli2, Claudio Bassi1, Roberto Salvia1.   

Abstract

BACKGROUND: Data on the reliability of the Ki-67 index and grading calculations from endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) of pancreatic neuroendocrine tumors (PanNETs) are controversial. We aimed to assess the accuracy of these data compared with histology.
METHODS: Cytological analysis from EUS-FNA in patients with suspected PanNETs (n = 110) were compared with resection samples at a single institution. A minimum of 2000 cells were considered to be adequate for grading. Correlation and agreement between cytology and histology in grading and Ki-67 values, respectively, were investigated. Secondary outcomes included the diagnostic performance of EUS-FNA.
RESULTS: EUS-FNA samples were adequate for PanNET diagnosis and PanNET grading in 98/110 (89.1 %) and 77/110 (70.0 %) patients, respectively; thus, 77 samples were adequate for comparing cytology vs. histology. There were 67 (62.0 %), 40 (36.4 %), and 1 (0.9 %) patients with a final diagnosis of G1, G2, and G3 tumors, respectively. EUS-FNA grading was concordant with surgical pathology in 81.8 % of patients; under- and overgrading occurred in 15.6 % and 2.6 %, respectively. The overall level of agreement for grading was moderate (Cohen's κ = 0.59, 95 % confidence interval [CI] 0.34 - 0.78). Spearman's rho for Ki-67 in tumors ≤ 20 mm and > 20 mm was strong and moderate, respectively (rho = 0.68, 95 %CI 0.47 - 0.83; rho = 0.59, 95 %CI 0.35 - 0.75). The Bland - Altman plot showed that the Ki-67 values were comparable and reproducible between the two measurements.
CONCLUSIONS: Although they were not available for a significant number of patients, grading and Ki-67 values from cytology correlated with histology moderately to strongly. Thieme. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32498099     DOI: 10.1055/a-1180-8614

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  12 in total

1.  Qualitative imaging features of pancreatic neuroendocrine neoplasms predict histopathologic characteristics including tumor grade and patient outcome.

Authors:  Motoyo Yano; Anup S Shetty; Greg A Williams; Samantha Lancia; Nikolaos A Trikalinos; Chet W Hammill; William G Hawkins; Amber Salter; Deyali Chatterjee
Journal:  Abdom Radiol (NY)       Date:  2022-02-15

2.  MRI Feature-Based Nomogram Model for Discrimination Between Non-Hypervascular Pancreatic Neuroendocrine Tumors and Pancreatic Ductal Adenocarcinomas.

Authors:  Jiake Xu; Jie Yang; Ye Feng; Jie Zhang; Yuqiao Zhang; Sha Chang; Jingqiang Jin; Xia Du
Journal:  Front Oncol       Date:  2022-05-19       Impact factor: 5.738

3.  Grading Pancreatic Neuroendocrine Tumors via Endoscopic Ultrasound-guided Fine Needle Aspiration: A Multi-Institutional Study.

Authors:  Ammar A Javed; Alessandra Pulvirenti; Samrah Razi; Jian Zheng; Theodoros Michelakos; Yurie Sekigami; Elizabeth Thompson; David S Klimstra; Vikram Deshpande; Aatur D Singhi; Matthew J Weiss; Christopher L Wolfgang; John L Cameron; Alice C Wei; Amer H Zureikat; Cristina R Ferrone; Jin He
Journal:  Ann Surg       Date:  2022-01-25       Impact factor: 13.787

4.  A New Preoperative Scoring System for Predicting Aggressiveness of Non-Functioning Pancreatic Neuroendocrine Neoplasms.

Authors:  Tetsuya Takikawa; Kazuhiro Kikuta; Shin Hamada; Kiyoshi Kume; Shin Miura; Naoki Yoshida; Yu Tanaka; Ryotaro Matsumoto; Mio Ikeda; Fumiya Kataoka; Akira Sasaki; Hidehiro Hayashi; Waku Hatta; Yohei Ogata; Kei Nakagawa; Michiaki Unno; Atsushi Masamune
Journal:  Diagnostics (Basel)       Date:  2022-02-03

5.  Complete Response After Pre-Operative Transcatheter Arterial Chemoembolization for Unresectable Primary Hepatic Neuroendocrine Tumour: A Case Report and Literature Review.

Authors:  Xinyuan Zhang; Huiru Yang; Yujing Xin; Yi Yang; Haizhen Lu; Xiang Zhou
Journal:  Front Oncol       Date:  2022-05-25       Impact factor: 5.738

6.  Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification.

Authors:  Matteo Tacelli; Maria Chiara Petrone; Gabriele Capurso; Francesca Muffatti; Valentina Andreasi; Stefano Partelli; Claudio Doglioni; Massimo Falconi; Paolo Giorgio Arcidiacono
Journal:  Endosc Ultrasound       Date:  2021 Sep-Oct       Impact factor: 5.628

7.  Endoscopic ultrasound-guided side-fenestrated needle biopsy sampling is sensitive for pancreatic neuroendocrine tumors but inadequate for tumor grading: a prospective study.

Authors:  Alexander Appelstrand; Fredrik Bergstedt; Anna-Karin Elf; Henrik Fagman; Per Hedenström
Journal:  Sci Rep       Date:  2022-04-08       Impact factor: 4.379

8.  The Sex Features of Patients With Solid Pseudopapillary Neoplasms of the Pancreas: A Retrospective Study.

Authors:  Guangmin Wei; Qiong Luo; Jiankai Fang; Xiaolou Li; Yanhong Shi; Yuqiong Li; Liqi Sun
Journal:  Front Oncol       Date:  2022-02-18       Impact factor: 6.244

9.  Prediction of Pancreatic Neuroendocrine Tumor Grading Risk Based on Quantitative Radiomic Analysis of MR.

Authors:  Wei Li; Chao Xu; Zhaoxiang Ye
Journal:  Front Oncol       Date:  2021-11-17       Impact factor: 6.244

Review 10.  The Utility of Endoscopic-Ultrasonography-Guided Tissue Acquisition for Solid Pancreatic Lesions.

Authors:  Hiroki Tanaka; Shimpei Matsusaki
Journal:  Diagnostics (Basel)       Date:  2022-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.